Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valérie Gounant

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
La Revue Du Praticien|March 19, 2021
[Prevention and screening for lung cancers: 10 key messages]Valérie Gounant
La Revue Du Praticien|March 19, 2021
[Prevention and screening for lung cancers]Valérie Gounant
La Revue Du Praticien|March 19, 2021
[Does lung cancer patients' survival increase?]Gérard Zalcman, Valérie Gounant
Annales De Pathologie|November 7, 2012
[Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). Experience of Tenon hospital (HU Est parisien, AP-HP Paris). The point of view of the pneumologist, the point of view of the cytologist]Valérie Gounant, Jocelyne Fleury-Feith
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
How do we do it?: another optimal methodology for endobronchial ultrasound sample handlingValérie Gounant, Jocelyne Fleury-Feith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2015
Pre-Emptive or Reactive Treatment of Cutaneous Rash Induced by Epidermal Growth Factor Receptor Inhibitors: Does It Matter?Gérard Zalcman, Solenn Brosseau, Valérie Gounant
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 23, 2019
Trials of Prophylactic Irradiation of Tracts: What is the Appropriate End Point?Gérard Zalcman, Solenn Brosseau, Valérie Gounant
Journal of Thoracic Disease|August 21, 2018
(J)ALEX the great: a new era in the world of ALK inhibitorsSolenn Brosseau, Valérie Gounant, Gérard Zalcman
Lung Cancer (Amsterdam, Netherlands)|May 17, 2020
Ongoing challenges of using immunotherapy in special populations: Poor performance status patients, elderly patients, and people living with HIVValérie Gounant, Armelle Lavolé, Elisabeth Quoix
Therapeutic Advances in Medical Oncology|December 17, 2021
Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatmentValérie Gounant, Solenn Brosseau, Gérard Zalcman
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
La Revue Du Praticien|March 19, 2021
[Prevention and screening for lung cancers: 10 key messages]Valérie Gounant
La Revue Du Praticien|March 19, 2021
[Prevention and screening for lung cancers]Valérie Gounant
La Revue Du Praticien|March 19, 2021
[Does lung cancer patients' survival increase?]Gérard Zalcman, Valérie Gounant
Annales De Pathologie|November 7, 2012
[Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). Experience of Tenon hospital (HU Est parisien, AP-HP Paris). The point of view of the pneumologist, the point of view of the cytologist]Valérie Gounant, Jocelyne Fleury-Feith
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
How do we do it?: another optimal methodology for endobronchial ultrasound sample handlingValérie Gounant, Jocelyne Fleury-Feith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2015
Pre-Emptive or Reactive Treatment of Cutaneous Rash Induced by Epidermal Growth Factor Receptor Inhibitors: Does It Matter?Gérard Zalcman, Solenn Brosseau, Valérie Gounant
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 23, 2019
Trials of Prophylactic Irradiation of Tracts: What is the Appropriate End Point?Gérard Zalcman, Solenn Brosseau, Valérie Gounant
Journal of Thoracic Disease|August 21, 2018
(J)ALEX the great: a new era in the world of ALK inhibitorsSolenn Brosseau, Valérie Gounant, Gérard Zalcman
Lung Cancer (Amsterdam, Netherlands)|May 17, 2020
Ongoing challenges of using immunotherapy in special populations: Poor performance status patients, elderly patients, and people living with HIVValérie Gounant, Armelle Lavolé, Elisabeth Quoix
Therapeutic Advances in Medical Oncology|December 17, 2021
Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatmentValérie Gounant, Solenn Brosseau, Gérard Zalcman
Pageof 9